Ind-Swift LaboratoriesNSE:INDSWFTLAB +3.85%55 Days Inventory is 219.59 as of Mar. 2026, which is 7% below its 10-year median of 237.31. GuruFocus rates NSE:INDSWFTLAB with a GF Score™ of 55/100 and a GF Value™ of ₹36.95 (Significantly Overvalued). The stock has 4 warning signs investors should review. Among 919 Drug Manufacturers companies, Ind-Swift Laboratories ranks worse than 67.9% on this metric.
The historical rank and industry rank for Ind-Swift Laboratories's Days Inventory or its related term are showing as below:
NSE:INDSWFTLAB'
s Days Inventory Range Over the Past 10 Years
Min: 93.96 Med: 237.31 Max: 271.13
Current: 215.41
During the past 13 years, Ind-Swift Laboratories's highest Days Inventory was 271.13. The lowest was 93.96. And the median was 237.31.
NSE:INDSWFTLAB's Days Inventory is ranked worse than 67.9% of 919
companies
in the Drug Manufacturers industry
Industry Median: 164.48
vs NSE:INDSWFTLAB: 215.41
Inventory Turnover measures how fast the company turns over its inventory within a year.
Ind-Swift Laboratories's Inventory Turnover for the
three
months ended in Mar. 2026 was 0.42.
Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.
Ind-Swift Laboratories's Inventory-to-Revenue for the
three
months ended in Mar. 2026 was 0.87.
Ind-Swift Laboratories (NSE:INDSWFTLAB) Days Inventory Explanation
Days Inventory indicates the liquidity of the inventory. Generally, a lower Days Inventory is preferred as it indicates a shorter duration to clear off the inventory. An increase of the ratio may indicate the company's sales slowed. Similar ratios related to Days Inventory are:
1. Inventory Turnover measures how fast the company turns over its inventory within a year.
Ind-Swift Laboratories's Inventory Turnover for the
three
months ended in Mar. 2026 is calculated as
2. Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.
Ind-Swift Laboratories's Inventory to Revenue for the
three
months ended in Mar. 2026 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Be Aware
A lot of business are seasonable. It makes more sense to compare Days Inventory from the same period in the previous year instead of from the previous quarter.
Ind-Swift Laboratories Days Inventory Related Terms
Ind-Swift Laboratories Days Inventory Historical Data
* Premium members only.
The historical data trend for Ind-Swift Laboratories's Days Inventory can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
NSE:INDSWFTLAB vs ZTS, UTHR: Days Inventory Comparison
For the Drug Manufacturers - Specialty & Generic subindustry, Ind-Swift Laboratories's Days Inventory, along with its competitors' market caps and Days Inventory data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Ind-Swift Laboratories Days Inventory vs Drug Manufacturers Industry
For the Drug Manufacturers industry and Healthcare sector, Ind-Swift Laboratories's Days Inventory distribution charts can be found below:
* The bar in red indicates where Ind-Swift Laboratories's Days Inventory falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Ind-Swift Laboratories (NSE:INDSWFTLAB) has a Days Inventory of 219.59 as of Mar. 2026. Days inventory represents the average amount of days a company holds inventory before selling it. View historical data on Ind-Swift Laboratories and its competitors. This is near median its historical median of 237.31. Over the past decade, Ind-Swift Laboratories' Days Inventory has ranged from 93.96 to 271.13. According to the industry distribution chart, Ind-Swift Laboratories ranks #624 out of 919 companies in the Drug Manufacturers industry, placing it in the top 67.9%.
Is Ind-Swift Laboratories' Days Inventory too high?
Ind-Swift Laboratories' current Days Inventory of 219.59 is near median its 10-year median of 237.31. Over the past 10 years, this metric has ranged from a low of 93.96 to a high of 271.13. The Drug Manufacturers industry median Days Inventory is 164.48. Ind-Swift Laboratories' value of 219.59 is 33.5% above this industry median. Based on the distribution chart, Ind-Swift Laboratories ranks #624 out of 919 companies in the Drug Manufacturers industry, which is below the industry midpoint. Overall, Ind-Swift Laboratories has a GF Score™ of 55/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Ind-Swift Laboratories' Days Inventory compare to ZTS and UTHR?
According to the Drug Manufacturers industry distribution chart, Ind-Swift Laboratories ranks #624 out of 919 companies for Days Inventory. This places Ind-Swift Laboratories in the lower half of its industry. The industry median Days Inventory is 164.48. Ind-Swift Laboratories' value of 219.59 is 33.5% above this benchmark. Historically, Ind-Swift Laboratories' own Days Inventory has ranged from 93.96 to 271.13 over the past decade. While the company's 10-year median is 237.31 vs. the industry median of 164.48, Ind-Swift Laboratories has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Days Inventory for a Drug Manufacturers company?
The median Days Inventory among Drug Manufacturers companies is 164.48, based on 919 companies in the industry. Companies in the top quartile (top 25%) have a Days Inventory significantly above this median, while those in the bottom quartile fall well below. However, Days Inventory should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Ind-Swift Laboratories's current Days Inventory of 219.59 is 33.5% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Days Inventory mean?
A high Days Inventory can signal that a stock is expensive relative to its fundamentals. Days inventory represents the average amount of days a company holds inventory before selling it. View historical data on Ind-Swift Laboratories and its competitors. For the Drug Manufacturers industry, the median Days Inventory is 164.48 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Ind-Swift Laboratories's current Days Inventory is 219.59, which is near median its own 10-year median of 237.31. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Ind-Swift Laboratories stock overvalued right now?
Based on GuruFocus' analysis, Ind-Swift Laboratories (NSE:INDSWFTLAB) is currently considered Significantly Overvalued. The stock's GF Value™ is ₹36.95, compared to a current price of ₹214.16 — trading 479.6% above its estimated fair value. The current Days Inventory is 219.59, which is near median its 10-year median of 237.31 and 33.5% above the Drug Manufacturers industry median of 164.48. Ind-Swift Laboratories' overall GF Score™ is 55/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Days Inventory calculated?
Days Inventory is calculated from a company's financial statements. For Ind-Swift Laboratories (NSE:INDSWFTLAB), the current Days Inventory is 219.59 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Ind-Swift Laboratories (NSE:INDSWFTLAB) Overvalued in 2026?
Based on GuruFocus' analysis, Ind-Swift Laboratories stock appears to be overvalued.
The current stock price of ₹214.16 is trading 479.6% above its estimated GF Value™ of ₹36.95.
GuruFocus considers Ind-Swift Laboratories to be Significantly Overvalued.
Key valuation signals for NSE:INDSWFTLAB:
Days Inventory: 219.59 (near median its 10-year median of 237.31)
GF Value™: ₹36.95 vs. price of ₹214.16 (479.6% above fair value)
Industry Position: 33.5% above the Drug Manufacturers median (#624 of 919)
No single metric tells the full story. See the NSE:INDSWFTLAB stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Ind-Swift Laboratories Ltd is involved in manufacturing Active Pharmaceutical Ingredients (API), Intermediates, and formulations. The company serves various therapeutic segments, including Cardiovascular health, Antihistamines, Antidiabetics, Antipsychotics, Parkinson's disease, Antineoplastics, ADHD Symptoms, Analgesics, Alcohol Abstinence, and Bone Resorption Inhibitors. It operates solely in the pharmaceutical products sector. Geographically, the company supplies both domestic and international markets, with the majority of its revenue coming from outside India.
55GF Score
Get the complete analysis for NSE:INDSWFTLAB
Days Inventory is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
NSE:INDSWFTLAB has been successfully added to your 
